+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Halogenated inhalational anaesthetics

Halogenated inhalational anaesthetics

Best Practice and Research. Clinical Anaesthesiology 17(1): 29-46

The halogenated inhalational anaesthetics halothane, enflurane, isoflurane and desflurane can produce metabolic hepatocellular injury in humans to a variable extent. During metabolism of these anaesthetics, tissue acetylation occurs due to the formation of reactive intermediates. Proteins modified by acetylation may constitute neo-antigens with a potential for triggering an antibody-mediated immune response. The likelihood of suffering post-operative immune hepatitis depends on the amount of the anaesthetic metabolized and is thereby considerably less with enflurane, isoflurane or desflurane compared with halothane. Plasma inorganic fluoride concentrations are regularly increased after sevoflurane. Elevated inorganic fluoride concentrations have been associated with nephrotoxicity following methoxyflurane anaesthesia but not after sevoflurane. Another source of concern is the products of degradation from reactions with carbon dioxide absorbents. Most important is compound A, which has been shown to exhibit nephrotoxicity in rodents. However, no significant changes in renal function parameters have been reported in surgical patients.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 049186144

Download citation: RISBibTeXText

PMID: 12751547

DOI: 10.1053/bean.2002.0265

Related references

Effects of halogenated inhalational anaesthetics on respiration in dogs. Comparative veterinary pharmacology, toxicology and therapy Proceedings of the 3rd Congress of the European Association for Veterinary Pharmacology and Toxicology: 25-32, 1986

Nephrotoxicity of halogenated inhalational anaesthetics: fictions and facts. European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes 34(1-2): 188-195, 2002

Nephrotoxicity of Halogenated Inhalational Anaesthetics: Fictions and Facts. European Surgical Research 34(1-2): 188-195, 2002

Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Practice and Research. Clinical Anaesthesiology 19(3): 523-538, 2005

New inhalational anaesthetics. Anaesthesist 45(8): 674-693, 1996

Inhalational anaesthetics. Anaesthesia & Intensive Care Medicine 9(12): 567-572, 2008

Inhalational anaesthetics. Anaesthesia & Intensive Care Medicine 16(12): 641-646, 2015

Inhalational anaesthetics. 2012

Inhalational anaesthetics: an update. Acta Anaesthesiologica Belgica 47(1): 3-6, 1996

Hepatotoxicity of inhalational anaesthetics. Current Opinion in Anaesthesiology 2(4): 414-417???417, 1989

Pharmacokinetics of Inhalational Anaesthetics. Lancet 2(7351): 143-145, 1964

Update on inhalational anaesthetics. Current Opinion in Anaesthesiology 22(4): 491-495, 2009

Inhalational anaesthetics and cardioprotection. Handbook of Experimental Pharmacology 2008(182): 187-207, 2008

The newer inhalational anaesthetics. Practitioner 161(965): 361-371, 1948

Inhalational anaesthetics in neurosurgery. Current Opinion in Anaesthesiology 7(5): 421-425, 1994